Demo Data from VLDB 2026 / reviewers in the wild / expert
Brian T. Luke
dblp:33/6789
· DBLP profile ↗
6ranked-venue papers
1as first author
3since 2021 · last 2024
0000-0002-2777-7376ORCID · corroborated
Domains — the database's venue-derived domains; a paper can count in several
Applied, interdisciplinary, general and emerging computing · 6 · 1 first-author · 3 since 2021
Expertise — from the expertise taxonomy: the topics of the expert's papers under the CCF categories. A weight counts papers with recency: 1 for a paper about the topic, 0.3 when the topic is its context, halved every five years.
| Interdisciplinary, comprehensive, and emerging computing
3 papers |
Bioinformatics and computational biology · 94% Medical and health informatics · 6% |
Topics — the 7 heaviest of 8, each with the papers that count most for it
| Topic | Weight | Papers | Last | Evidence papers |
|---|---|---|---|---|
Bioinformatics and computational biology › genomics
genome visualization |
0.7 | 2 | 2021 | AVIA 3.0: interactive portal for genomic variant and sample level analysis · Bioinform. 2021 AVIA v2.0: annotation, visualization and impact analysis of genomic variants and genes · Bioinform. 2015 |
Bioinformatics and computational biology › sequence analysis › RNA sequence analysis
microRNA analysis |
0.5 | 1 | 2021 | Tumor IsomiR Encyclopedia (TIE): a pan-cancer database of miRNA isoforms · Bioinform. 2021 |
Bioinformatics and computational biology › genomics
genomic variant analysis |
0.2 | 1 | 2015 | AVIA v2.0: annotation, visualization and impact analysis of genomic variants and genes · Bioinform. 2015 |
Bioinformatics and computational biology › genomics
variant annotation |
0.2 | 1 | 2015 | AVIA v2.0: annotation, visualization and impact analysis of genomic variants and genes · Bioinform. 2015 |
Bioinformatics and computational biology › functional genomics
variant functional annotation |
0.2 | 1 | 2015 | AVIA v2.0: annotation, visualization and impact analysis of genomic variants and genes · Bioinform. 2015 |
Bioinformatics and computational biology
cancer genomics |
0.1 | 1 | 2021 | AVIA 3.0: interactive portal for genomic variant and sample level analysis · Bioinform. 2021 |
Bioinformatics and computational biology › genomics
variant analysis |
0.1 | 1 | 2021 | AVIA 3.0: interactive portal for genomic variant and sample level analysis · Bioinform. 2021 |
Methods — techniques the papers use, named apart from their topics
sequence variant aggregation · 0.5database construction · 0.5ANNOVAR · 0.2
| Year | Publication | Venue | Position |
|---|---|---|---|
| 2024 | MoCoLo: a testing framework for motif co-localizationabstractSequence-level data offers insights into biological processes through the interaction of two or more genomic features from the same or different molecular data types. Within motifs, this interaction is often explored via the co-occurrence of feature genomic tracks using fixed-segments or analytical tests that respectively require window size determination and risk of false positives from over-simplified models. Moreover, methods for robustly examining the co-localization of genomic features, and thereby understanding their spatial interaction, have been elusive. We present a new analytical method for examining feature interaction by introducing the notion of reciprocal co-occurrence, define statistics to estimate it and hypotheses to test for it. Our approach leverages conditional motif co-occurrence events between features to infer their co-localization. Using reverse conditional probabilities and introducing a novel simulation approach that retains motif properties (e.g. length, guanine-content), our method further accounts for potential confounders in testing. As a proof-of-concept, motif co-localization (MoCoLo) confirmed the co-occurrence of histone markers in a breast cancer cell line. As a novel analysis, MoCoLo identified significant co-localization of oxidative DNA damage within non-B DNA-forming regions that significantly differed between non-B DNA structures. Altogether, these findings demonstrate the potential utility of MoCoLo for testing spatial interactions between genomic features via their co-localization. Imee M. A del Mundo, Maha Zewail-Foote, Brian T. Luke, Karen M. Vasquez, Jeanne Kowalski |
Briefings Bioinform. | 4 |
| 2021 | AVIA 3.0: interactive portal for genomic variant and sample level analysisabstractSUMMARY: The Annotation, Visualization and Impact Analysis (AVIA) is a web application combining multiple features to annotate and visualize genomic variant data. Users can investigate functional significance of their genetic alterations across samples, genes and pathways. Version 3.0 of AVIA offers filtering options through interactive charts and by linking disease relevant data sources. Newly incorporated services include gene, variant and sample level reporting, literature and functional correlations among impacted genes, comparative analysis across samples and against data sources such as TCGA and ClinVar, and cohort building. Sample and data management is now feasible through the application, which allows greater flexibility with sharing, reannotating and organizing data. Most importantly, AVIA's utility stems from its convenience for allowing users to upload and explore results without any a priori knowledge or the need to install, update and maintain software or databases. Together, these enhancements strengthen AVIA as a comprehensive, user-driven variant analysis portal. AVAILABILITYAND IMPLEMENTATION: AVIA is accessible online at https://avia-abcc.ncifcrf.gov. Hue V. Reardon, Anney Che, Brian T. Luke, Sarangan Ravichandran, Jack R. Collins, Uma Mudunuri |
Bioinform. | 3 |
| 2021 | Tumor IsomiR Encyclopedia (TIE): a pan-cancer database of miRNA isoformsabstractSUMMARY: MicroRNAs (miRNAs) are master regulators of gene expression in cancers. Their sequence variants or isoforms (isomiRs) are highly abundant and possess unique functions. Given their short sequence length and high heterogeneity, mapping isomiRs can be challenging; without adequate depth and data aggregation, low frequency events are often disregarded. To address these challenges, we present the Tumor IsomiR Encyclopedia (TIE): a dynamic database of isomiRs from over 10 000 adult and pediatric tumor samples in The Cancer Genome Atlas (TCGA) and The Therapeutically Applicable Research to Generate Effective Treatments (TARGET) projects. A key novelty of TIE is its ability to annotate heterogeneous isomiR sequences and aggregate the variants obtained across all datasets. Results can be browsed online or downloaded as spreadsheets. Here, we show analysis of isomiRs of miR-21 and miR-30a to demonstrate the utility of TIE. AVAILABILITY AND IMPLEMENTATION: TIE search engine and data are freely available to use at https://isomir.ccr.cancer.gov/. SUPPLEMENTARY INFORMATION: Supplementary data are available at Bioinformatics online. Xavier Bofill-De Ros, Brian T. Luke, Robert Guthridge, Uma Mudunuri, Michael A. Loss, Shuo Gu |
Bioinform. | 2 |
| 2015 | AVIA v2.0: annotation, visualization and impact analysis of genomic variants and genesabstractUNLABELLED: As sequencing becomes cheaper and more widely available, there is a greater need to quickly and effectively analyze large-scale genomic data. While the functionality of AVIA v1.0, whose implementation was based on ANNOVAR, was comparable with other annotation web servers, AVIA v2.0 represents an enhanced web-based server that extends genomic annotations to cell-specific transcripts and protein-level functional annotations. With AVIA's improved interface, users can better visualize their data, perform comprehensive searches and categorize both coding and non-coding variants. AVAILABILITY AND IMPLEMENTATION: AVIA is freely available through the web at http://avia.abcc.ncifcrf.gov. CONTACT: [email protected] SUPPLEMENTARY INFORMATION: Supplementary data are available at Bioinformatics online. Hue Vuong, Anney Che, Sarangan Ravichandran, Brian T. Luke, Jack R. Collins, Uma Mudunuri |
Bioinform. | 4 |
| 2008 | Examining the significance of fingerprint-based classifiersabstractBACKGROUND: Experimental examinations of biofluids to measure concentrations of proteins or their fragments or metabolites are being explored as a means of early disease detection, distinguishing diseases with similar symptoms, and drug treatment efficacy. Many studies have produced classifiers with a high sensitivity and specificity, and it has been argued that accurate results necessarily imply some underlying biology-based features in the classifier. The simplest test of this conjecture is to examine datasets designed to contain no information with classifiers used in many published studies. RESULTS: The classification accuracy of two fingerprint-based classifiers, a decision tree (DT) algorithm and a medoid classification algorithm (MCA), are examined. These methods are used to examine 30 artificial datasets that contain random concentration levels for 300 biomolecules. Each dataset contains between 30 and 300 Cases and Controls, and since the 300 observed concentrations are randomly generated, these datasets are constructed to contain no biological information. A modest search of decision trees containing at most seven decision nodes finds a large number of unique decision trees with an average sensitivity and specificity above 85% for datasets containing 60 Cases and 60 Controls or less, and for datasets with 90 Cases and 90 Controls many DTs have an average sensitivity and specificity above 80%. For even the largest dataset (300 Cases and 300 Controls) the MCA procedure finds several unique classifiers that have an average sensitivity and specificity above 88% using only six or seven features. CONCLUSION: While it has been argued that accurate classification results must imply some biological basis for the separation of Cases from Controls, our results show that this is not necessarily true. The DT and MCA classifiers are sufficiently flexible and can produce good results from datasets that are specifically constructed to contain no information. This means that a chance fitting to the data is possible. All datasets used in this investigation are available on the web. Brian T. Luke, Jack R. Collins |
BMC Bioinform. | 1 |
| 2008 | Polymorphism Interaction Analysis (PIA): a method for investigating complex gene-gene interactionsabstractBACKGROUND: The risk of common diseases is likely determined by the complex interplay between environmental and genetic factors, including single nucleotide polymorphisms (SNPs). Traditional methods of data analysis are poorly suited for detecting complex interactions due to sparseness of data in high dimensions, which often occurs when data are available for a large number of SNPs for a relatively small number of samples. Validation of associations observed using multiple methods should be implemented to minimize likelihood of false-positive associations. Moreover, high-throughput genotyping methods allow investigators to genotype thousands of SNPs at one time. Investigating associations for each individual SNP or interactions between SNPs using traditional approaches is inefficient and prone to false positives. RESULTS: We developed the Polymorphism Interaction Analysis tool (PIA version 2.0) to include different approaches for ranking and scoring SNP combinations, to account for imbalances between case and control ratios, stratify on particular factors, and examine associations of user-defined pathways (based on SNP or gene) with case status. PIA v. 2.0 detected 2-SNP interactions as the highest ranking model 77% of the time, using simulated data sets of genetic models of interaction (minor allele frequency = 0.2; heritability = 0.01; N = 1600) generated previously [Velez DR, White BC, Motsinger AA, Bush WS, Ritchie MD, Williams SM, Moore JH: A balanced accuracy function for epistasis modeling in imbalanced datasets using multifactor dimensionality reduction. Genet Epidemiol 2007, 31:306-315.]. Interacting SNPs were detected in both balanced (20 SNPs) and imbalanced data (case:control 1:2 and 1:4, 10 SNPs) in the context of non-interacting SNPs. CONCLUSION: PIA v. 2.0 is a useful tool for exploring gene*gene or gene*environment interactions and identifying a small number of putative associations which may be investigated further using other statistical methods and in replication study populations. Leah E. Mechanic, Brian T. Luke, Julie E. Goodman, Stephen J. Chanock, Curtis C. Harris |
BMC Bioinform. | 2 |